As shown in Fig. 6G, CRMP2+/α-SMA+ co-expression group accounted for 60.66% overall, and positively correlated with tumor metastases and an unsatisfactory prognosis (P = 0.0437) (Fig. 6H). This evidence concerns the gene DPYSL2 and neoplasm.